Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient

American Journal of Dermatopathology

Volumn 35, Issue 1, 2013, Pages 11-18

  Fujiwara, Mika ^a   Morales, Anjali V ^b   Seo, Katie ^a   Kim, Youn H ^b   Arber, Daniel A ^a   Sundram, Uma N ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BIOMED 2; Clonality; Cutaneous B cell lymphoma; PCR

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; PRIMARY CUTANEOUS B CELL LYMPHOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; CASE-CONTROL STUDIES; CLONE CELLS; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84873404827     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318255dbae     Document Type: Article

References (25)

1. Bradford PT, Devesa SS, Anderson WF, et al. Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases. Blood. 2009;113:5064-5073.
2. Swerdlow SH, Campo E, Harris NL, et al, eds. Mature B cell neoplasms. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2008:179-267.
3. Evans PA, Pott CH, Groenen PJ, et al. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 concerted action BHM4-CT98- 3936. Leukemia. 2007;21:207-214.
4. Lukowsky A, Marchwat M, Sterry W, et al. Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reaction. Leuk Lymphoma. 2006;47:487-493.
5. van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317.
6. van Krieken JH, Langerak AW, Macintyre EA, et al. Improved reliability of lymphoma diagnostics via PCR-based clonality testing: Report of the BIOMED-2 concerted action BHM4-CT98-3936. Leukemia. 2007;21: 201-206.
7. Morales AV, Arber DA, Seo K, et al. Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol. 2008; 30:425-430.
8. Thurber SE, Zhang B, Kim YH, et al. T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J Am Acad Dermatol. 2007;57:782-790.
9. Hoefnagel JJ, Mulder MM, Dreef E, et al. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma. Mod Pathol. 2006; 19:1270-1276.
10. Hughes J, Weston S, Bennetts B, et al. The application of a PCR technique for the detection of immunoglobulin heavy chain gene rearrangements in fresh or paraffin-embedded skin tissue. Pathology. 2001;33: 222-225.
11. Bouloc A, Delfau-Larue MH, Lenormand B, et al. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas. Arch Dermatol. 1999;135:168-172.
12. Child FJ, Woolford AJ, Calonje E, et al. Molecular analysis of the immunoglobulin heavy chain gene in the diagnosis of primary cutaneous B cell lymphoma. J Invest Dermatol. 2001;117:984-989.
13. Ritter JH, Wick MR, Adesokan PN, et al. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Am J Clin Pathol. 1997;108:60-68.
14. Cerroni L, Arzberger E, Putz B, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood. 2000;95:3922-3928.
15. Cerroni L, Minkus G, Putz B, et al. Laser beam microdissection in the diagnosis of cutaneous B cell lymphoma. Br J Dermatol. 1997;136:743-746.
16. Meeker T, Loweder J, Cleary ML, et al. Emergence of idiotype variants during treatment of B cell lymphoma with anti-idiotype antibodies. N Engl J Med. 1985;312:1658-1665.
17. Konoplev S, Lin P, Qiu X, et al. Clonal relationship of extranodal marginal zone lymphomas of mucosa associated lymphoid tissue involving different sites. Am J Clin Pathol. 2010;134:112-118.
18. Du MQ, Xu CF, Diss TC, et al. Intestinal dissemination of gastric mucosa associated lymphoid tissue lymphoma. Blood. 1996;88:4445-4451.
19. Molina A. A decade of rituximab: Improving survival outcomes in non- Hodgkin's lymphoma. Annu Rev Med. 2008;59:237-250.
20. Kerl K, Prins C, Saurat JH, et al. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: Report and follow-up of eight cases. Br J Dermatol. 2006;155: 1197-1200.
21. Kyrtsonis MC, Siakantaris MP, Kalpadakis C, et al. Favourable outcome of primary cutaneous marginal zone lymphoma treated with intralesional rituximab. Eur J Haematol. 2006;77:300-303.
22. Heinzerling LM, Urbanek M, Funk JO, et al. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer. 2000;89:1835-1844.
23. Valencak J, Weihsengruber F, Rappersberger K, et al. Rituximab monotherapy for primary cutaneous B-cell lymphoma: Response and follow-up in 16 patients. Ann Oncol. 2009;20:326-330.
24. Morales AV, Advani R, Horwitz SM, et al. Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab. J Am Acad Dermatol. 2008;59:953-957.
25. Senff NJ, Noordijk EM, Kim YH, et al, European Organization for Research and Treatment of Cancer; International Society for Cutaneous Lymphoma. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Blood. 2008;112:1600-1609.